Name: UMIN ID:
Unique ID issued by UMIN | UMIN000012389 |
---|---|
Receipt number | R000014487 |
Scientific Title | Phase 2 study of pretreatment with hydroxyurea prior to induction therapy for patients with newly diagnosed acute myeloid leukemia (PREFACE study) |
Date of disclosure of the study information | 2013/11/25 |
Last modified on | 2019/05/31 23:46:10 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/11/23 14:49:54 | ||
2 | Update | 2016/11/24 19:17:59 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
3 | Update | 2018/01/31 10:54:46 | Last name of lead principal investigator Last name of lead principal investigator TEL Last name of contact person Last name of contact person TEL Name of person sending information Name of person sending information TEL Name of primary person or sponsor Organization |
|
4 | Update | 2018/11/27 07:51:50 | UMIN ID1 |
|
5 | Update | 2019/05/31 23:37:16 | Recruitment status Date of IRB Last follow-up date |
|
6 | Update | 2019/05/31 23:45:08 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
7 | Update | 2019/05/31 23:46:10 | Number of participants that the trial has enrolled |